BioCentury
ARTICLE | Financial News

Vical planning follow-on

January 6, 2012 2:21 AM UTC

Vical Inc. (NASDAQ:VICL) proposed late Thursday to sell shares in a follow-on underwritten by Citi; Credit Suisse; Leerink; and Rodman. Details were not disclosed. Vical's Allovectin is in Phase III t...